Asp299Gly and Thr399Ile polymorphism of TLR-4 gene in patients with prostate cancer from North India

Indian Journal of Urology

Volumn 29, Issue 1, 2013, Pages 37-41

  Priyadarshini, Anjali ^a   Chakraborti, Anuradha ^a   Mandal, Arup K ^a   Singh, Shrawan K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Gene polymorphism; prostate cancer; TLR 4; toll like receptor 4

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TOLL LIKE RECEPTOR 4;

ADULT; ARTICLE; BLOOD SAMPLING; CANCER PATIENT; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; DNA DETERMINATION; DNA ISOLATION; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSURVEILLANCE; INDIA; INNATE IMMUNITY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATE SIZE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION SITE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84876868837     PISSN: 09701591     EISSN: 19983824     Source Type: Journal    
DOI: 10.4103/0970-1591.109982     Document Type: Article

References (22)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-6
2. Sobti RC, Gupta L, Thakur H, Seth H, Seth A, Singh SK, et al. CyP17 gene polymorphism and its association in North Indian Prostate Cancer patients. Anticancer Res 2009;29:1659-63
3. Gupta L, Thakur H, Sobti RC, Seth A, Singh SK. Role of genetic polymorphism of estrogen receptor-alpha gene and risk of Prostate Cancer in North Indian population. Mol Cell Biochem 2010;335:255-61
4. De Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: Implications for prostatic carcinogenesis. Am J Pathol 1999;155:1985-92
5. De Marzo AM, Deweese TL, Platz EA, Meekar AK, Nakayama M, Epstein JI, et al. Pathological and molecular mechanisms of prostate carcinogenesis: Implications for diagnosis, detection, prevention, and treatment. J Cell Biochem 2004;91:459-77
6. Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Cancer Res 2005;65:11771-8
7. Sun J, Wiklund F, Zheng SL, Chang B, Balter K, Li L, et al. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. J Natl Cancer Inst 2005;97:525-32
8. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000;25:187-91
9. Lorenz E, Mira JP, Cornish KL, Arbour NC, Schwartz DA. A novel polymorphism in the toll like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun 2000;68:6398-401
10. Kiechl S, Lorenz E, Reindl M, Wiederman CJ, Oberhollenzer F, Bonora E, et al. Toll like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002;347:185-92
11. Mockenhaupt FP, Cramer JP, Hamann L, Stegemann MS, Eckert J, Oh N, et al. Toll-like receptor (TLR) polymorphisms in African children: Common TLR-4 variants predispose to severe malaria. Proc Natl Acad Sci USA 2006;103:177-82
12. Santini D, Angeletti S, Ruzzo A, Dicuonzo G, Galluzos S, Vincenzi B, et al. Toll-like receptor-4 Asp299Gly and Thr399Ile polymorphism in gastric cancer of intestinal and diffuse histotype. Clin Exp Immunol 2008;154:360-4
13. Achut BR, Ghishal UC, Moorchung N, Mittal B. Association of Toll like receptor-4 (Asp299Gly and Thr399Ile) gene polymorphism with gastritis and precancerous lesions. Human Immunol 2007;68:901-7
14. Gleason DF, Mellinger GT. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974;111:58-64
15. Lahiri DK, Bye S, Nurnberger JI Jr, Hodes ME, Crisp M. A non organic and non enzymatic extraction method gives higher yield of genomic DNA from whole blood sample than do other methods tested. J Biochem Biophys Methods 1992;25:193-205
16. Lorenz E, Frees KL, Schwartz DA. Determination of the TLR4 genotype using allele-specific PCR. Biotechniques 2001;31:22-4
17. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-76
18. Lin YC, Chang YM, Yu JM, Yen JH, Chang JC, Hu CJ. Toll-like receptor 4 gene C119A but no Asp299Gly polymorphism is associated with ischemic stroke among ethnic Chinese in Taiwan. Atherosclerosis 2005;180:305-9
19. Nakada TA, Hirasawa H, Oda S, Shiga H, Matsuda K, Nakamura M, et al. Influence of toll-like receptor 4, CD14, tumor necrosis factor, and interleukine-10 gene polymorphisms on clinical outcome in Japanese critically ill patients. J Surg Res 2005;129:322-8
20. Ferwerda B, McCall BB, Verheijen K, Kullberg BJ, van der Ven AJ, Van der Meer JW, et al. Functional consequecces of Toll like receptor-4 polymorphisms. Mol Med 2008;14:346-52
21. Zheng SL, Liu W, Dimitrov L, Sun J, Chang B, Loza B, et al. A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study. Prostate 2006;66:1556-64
22. Macarthur M, Hold GL, El-Omar E. Inflammation and cancer. Role of Chronic inflammation and cytokine gene polymorphism in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 2004;286:G515-20